About Diabetes Associates Medical Group
Clinical Trials at Diabetes Associates Medical Group
During the past decade, Diabetes Associates Medical Group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Diabetes Associates Medical Group" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Pfizer" with 2 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Grifols Therapeutics LLC" with 1 trials sponsored and "Teijin America, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetes Associates Medical Group"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Diabetes Associates Medical Group
According to Clinical.Site data, the most researched conditions in "Diabetes Associates Medical Group" are
"Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetic Kidney Disease" (1 trials), "Hypertension" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Diabetes Associates Medical Group" in a lesser frequency.
Clinical Trials Intervention Types at Diabetes Associates Medical Group
Most popular intervention types in "Diabetes Associates Medical Group" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Tirzepatide" (2 trials), "bococizumab (PF-04950615)" (2 trials), "180 mg/kg Alpha1-PI" (1 trials) and "90 mg/kg Alpha1-PI" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Diabetes Associates Medical Group
The vast majority of trials in "Diabetes Associates Medical Group" are
8 trials for "All" genders.
Clinical Trials Status at Diabetes Associates Medical Group
Currently, there are NaN active trials in "Diabetes Associates Medical Group".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Diabetes Associates Medical Group,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Diabetes Associates Medical Group, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".